We have collected information about Codman Drug Delivery Pump for you. Follow the links to find out details on Codman Drug Delivery Pump.
http://productdirectory.clinicaladvisor.com/products/1446/codman_3000_implantable_drug_pump
The CODMAN 3000 drug pump is a proven implantable drug delivery system for the delivery of medications to treat chronic pain, severe spasticity, and cancers of the liver.This elegantly simple device features an inexhaustible power supply, and does not require the frequent replacement surgeries associated with battery-powered pumps.
https://www.jnjmedicaldevices.com/en-US/codman-pumps/patient-support
The CODMAN® 3000 Constant Flow Pump is a small drug delivery system which is completely implanted beneath the skin. Depending upon the model selected by your doctor, the pump is about two to three inches in diameter, 3/4 to one inch thick, weighing four to six ounces, and approximately the size of a hockey puck.
https://www.nature.com/articles/3101684
Nov 16, 2004 · The Codman Model 3000 Constant Flow Implantable Infusion Pump is an accurate, reliable, convenient, and efficacious option for patients needing intrathecal drug therapy. The complication rates are similar to other pumps, and are not pump specific but rather catheter, medication, or wound related.Author: K D Ethans, O I Schryvers, P W Nance, A R Casey
https://www.medgadget.com/2012/08/codmans-medstream-infusion-system-for-spinal-drug-deliver-gets-fda-ok.html
Codman, now a part of Johnson & Johnson, just announced FDA clearance for its MEDSTREAM Programmable Infusion System, a drug pump that delivers baclofen to the spinal canal in a very controlled manner. The system, that already has European approval,...
https://www.drugdeliverybusiness.com/report-jjs-cerenovus-to-discontinue-codman-liver-cancer-pump/
Apr 26, 2018 · April 26, 2018 By Fink Densford Johnson & Johnson ‘s (NYSE: JNJ) Cerenovus is discontinuing production of its Codman pumps designed to deliver targeted chemotherapy to the liver for patients with liver cancer, according to a New York Times report.
https://clinicaltrials.gov/ct2/show/NCT03693807
Oct 03, 2018 · A Pilot Protocol Evaluating Safety of Using the Medtronic Pump and Codman Catheter for the Delivery of Hepatic Arterial Infusion (HAI) Chemotherapy in Patients With Colorectal Carcinoma or Cholangiocarcinoma: Actual Study Start Date : October 18, 2018: Estimated Primary Completion Date : September 2020: Estimated Study Completion Date ...
Searching for Codman Drug Delivery Pump?
You can just click the links above. The data is collected for you.
